CA2269668A1 - Famille de taxanes canadensol, preparation semi-synthetique et usage therapeutique de ces derniers - Google Patents

Famille de taxanes canadensol, preparation semi-synthetique et usage therapeutique de ces derniers Download PDF

Info

Publication number
CA2269668A1
CA2269668A1 CA002269668A CA2269668A CA2269668A1 CA 2269668 A1 CA2269668 A1 CA 2269668A1 CA 002269668 A CA002269668 A CA 002269668A CA 2269668 A CA2269668 A CA 2269668A CA 2269668 A1 CA2269668 A1 CA 2269668A1
Authority
CA
Canada
Prior art keywords
compound
methyl
propyl
hydroxy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002269668A
Other languages
English (en)
Inventor
Lolita Zamir
Gaetan Caron
Yi Feng Zheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de La Recherche Scientifique INRS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2188714 external-priority patent/CA2188714A1/fr
Priority claimed from CA 2197369 external-priority patent/CA2197369A1/fr
Application filed by Individual filed Critical Individual
Priority to CA002269668A priority Critical patent/CA2269668A1/fr
Priority claimed from PCT/CA1997/000790 external-priority patent/WO1998017656A1/fr
Publication of CA2269668A1 publication Critical patent/CA2269668A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

La présente invention concerne un nouveau taxane présentant la structure décrite dans la formule (I) et ses analogues décrits dans la formule (II) et la formule (III). La présente invention comprend de nouveaux procédés semi-synthétiques et d'isolement permettant de préparer ces nouveaux taxanes. Plus particulièrement, l'invention se rapporte à un nouveau taxane Canadensol isolé à partir des plantes du genre Taxus, en particulier Taxus canadensis. L'invention concerne également l'utilisation de ces nouveaux taxanes comme agents anticancéreux.
CA002269668A 1996-10-24 1997-10-24 Famille de taxanes canadensol, preparation semi-synthetique et usage therapeutique de ces derniers Abandoned CA2269668A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002269668A CA2269668A1 (fr) 1996-10-24 1997-10-24 Famille de taxanes canadensol, preparation semi-synthetique et usage therapeutique de ces derniers

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CA 2188714 CA2188714A1 (fr) 1996-10-24 1996-10-24 Taxanes, methode de preparation et compositions pharmaceutiques a base de ces produits
CA2,188,714 1996-10-24
CA2,197,369 1997-02-12
CA 2197369 CA2197369A1 (fr) 1997-02-12 1997-02-12 Nouvelles taxanes, leur preparation et compositions pharmaceutiques en contenant
CA002269668A CA2269668A1 (fr) 1996-10-24 1997-10-24 Famille de taxanes canadensol, preparation semi-synthetique et usage therapeutique de ces derniers
PCT/CA1997/000790 WO1998017656A1 (fr) 1996-10-24 1997-10-24 Famille de taxanes canadensol, preparation semi-synthetique et usage therapeutique de ces derniers

Publications (1)

Publication Number Publication Date
CA2269668A1 true CA2269668A1 (fr) 1998-04-30

Family

ID=29715691

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002269668A Abandoned CA2269668A1 (fr) 1996-10-24 1997-10-24 Famille de taxanes canadensol, preparation semi-synthetique et usage therapeutique de ces derniers

Country Status (1)

Country Link
CA (1) CA2269668A1 (fr)

Similar Documents

Publication Publication Date Title
RU2139864C1 (ru) Таксоиды, способы их получения, промежуточные соединения и фармацевтическая композиция
US5847170A (en) Taxoids, their preparation and pharmaceutical compositions containing them
US6387946B1 (en) Methods for treating pathological conditions of abnormal cell proliferation
KR100500351B1 (ko) 택소이드, 이의 제조방법 및 이를 함유하는 약학 조성물
JP3441458B2 (ja) 7‐ハロ‐および7β,8β‐メタノ‐タキソール、抗新生物剤としての使用およびそれを含有する医薬組成物
UOTo et al. Synthesis and structure-activity relationships of novel 2', 2'-difluoro analogues of docetaxel
SK50793A3 (en) Method for preparing taxane derivatives, novel derivatives thereby obtained and pharmaceutical compositions containing same
JPH06329650A (ja) 2−脱ベンゾイル−2−アシルタキソール誘導体及びこれらを製造する方法
Ojima et al. Synthesis and structure-activity relationships of new antitumor taxoids. Effects of cyclohexyl substitution at the C-3'and/or C-2 of taxotere (docetaxel)
AU688916B2 (en) 7-0-ethers of taxane derivatives
US6410756B1 (en) Family of Canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof
US6372780B2 (en) Methods of treating cell lines expressing multidrug resistance P-glycoprotein
IL117760A (en) Taxoids, their preparation and pharmaceutical preparations containing them
US6476242B1 (en) 2-aroyl-4-acyl paclitaxel (Taxol) analogs
SK139994A3 (en) Taxane derivatives, their preparation and compositions containing same
FR2721023A1 (fr) Nouveaux Taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
DE60111614T2 (de) Taxan-derivate für die behandlung von krebs
SK13632001A3 (sk) C10 karbonátom substituované taxány ako protinádorové činidlá
CA2269668A1 (fr) Famille de taxanes canadensol, preparation semi-synthetique et usage therapeutique de ces derniers
WO1998047360A1 (fr) Paclitaxels 7-soufre substitues
CA2282264A1 (fr) Paclitaxels 7-methylthiooxomethyle et 7-methylthiodioxomethyle
CA2197369A1 (fr) Nouvelles taxanes, leur preparation et compositions pharmaceutiques en contenant
CA2188714A1 (fr) Taxanes, methode de preparation et compositions pharmaceutiques a base de ces produits
WO1999032109A1 (fr) Paclitaxels portant un substituant 7-desoxy-6-azote

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued